title: Epithelial-mesenchymal transition associates with maintenance of stemness in spheroid-derived stem-like colon cancer cells.
abstract: Despite earlier studies demonstrating characteristics of colon cancer stem cells (CCSCs) and the role of epithelial-mesenchymal transition (EMT) in tumor development, it remains controversial as to the relationship between CCSCs and EMT. In this study, in order to present an insight into this relationship in colon cancer, we developed HCT116 and HT29 sphere models, which are known to be the cells enriching cancer stem cells. Compared to their parental counterparts, spheroid cells displayed lower homotypic/heterotypic adhesion but higher in vitro migratory/invasive capacity, as well as higher tumorigenic and metastatic potential in vivo. The spheroid cells also demonstrated down-regulated E-cadherin and up-regulated α-SMA and Vimentin expression, which is the typical phenotype of EMT. In order to explore whether this phenomenon is associated to activation of Wnt/β-catenin pathway, we detected several key signaling molecules. Compared with their parental cells, HCT116 and HT29 spheroid cells demonstrated down-regulated expression of GSK3β, but up-regulated expression of Slug and Snail. And also, the up-regulation of nucleus β-catenin in spheroid cells indicated that the free β-catenin transferred from cytoplasm to cell nucleus. Our findings indicate that spheroid cells have the characteristics of colon cancer stem cells, and EMT may account for their stemness and malignancy. And persistent activation of Wnt/β-catenin pathway may play an important role in the EMT of CCSCs.
authors.affiliation: Central Laboratory, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
authors.forename: Xiao-Yan
authors.initials: XY
authors.lastname: Han
authors.forename: Bo
authors.initials: B
authors.lastname: Wei
authors.forename: Jia-Feng
authors.initials: JF
authors.lastname: Fang
authors.forename: Shi
authors.initials: S
authors.lastname: Zhang
authors.forename: Fu-Cheng
authors.initials: FC
authors.lastname: Zhang
authors.forename: Hai-Bo
authors.initials: HB
authors.lastname: Zhang
authors.forename: Tian-Yun
authors.initials: TY
authors.lastname: Lan
authors.forename: Hui-Qiong
authors.initials: HQ
authors.lastname: Lu
authors.forename: Hong-Bo
authors.initials: HB
authors.lastname: Wei
mesh_terms: D000199:Actins / Q000235:genetics / Q000378:metabolism; D045744:Cell Line, Tumor; D003110:Colonic Neoplasms / Q000235:genetics / Q000378:metabolism / Q000473:pathology*; D015536:Down-Regulation; D058750:Epithelial-Mesenchymal Transition; D015972:Gene Expression Regulation, Neoplastic; D019073:HT29 Cells; D006801:Humans; D014411:Neoplastic Stem Cells / Q000166:cytology / Q000378:metabolism / Q000473:pathology*; D018874:Spheroids, Cellular / Q000166:cytology / Q000378:metabolism / Q000473:pathology*; D015854:Up-Regulation; D014746:Vimentin / Q000235:genetics / Q000378:metabolism; D060449:Wnt Signaling Pathway; D051176:beta Catenin / Q000235:genetics / Q000378:metabolism
chemical_list: C541116:ACTA2 protein, human; D000199:Actins; D014746:Vimentin; D051176:beta Catenin
references.citation: Clin Exp Metastasis. 2007;24(8):587-97
references.pmid: 17978854
references.citation: Nature. 2007 Jan 4;445(7123):111-5
references.pmid: 17122771
references.citation: Science. 1997 Mar 21;275(5307):1787-90
references.pmid: 9065402
references.citation: Int J Biochem Cell Biol. 2004 May;36(5):759-65
references.pmid: 15061130
references.citation: Nature. 2004 Nov 18;432(7015):396-401
references.pmid: 15549107
references.citation: Proc Natl Acad Sci U S A. 2009 Aug 18;106(33):13820-5
references.pmid: 19666588
references.citation: Cancer Biol Ther. 2010 Jul 15;10(2):198-208
references.pmid: 20534975
references.citation: Cells Tissues Organs. 2005;179(1-2):56-65
references.pmid: 15942193
references.citation: J Biol Chem. 2005 Mar 25;280(12):11740-8
references.pmid: 15647282
references.citation: Nat Rev Cancer. 2005 Sep;5(9):744-9
references.pmid: 16148886
references.citation: Cancer Res. 2007 Apr 15;67(8):3716-24
references.pmid: 17440084
references.citation: Annu Rev Biochem. 2007;76:593-627
references.pmid: 17373907
references.citation: Lancet Oncol. 2007 Sep;8(9):773-83
references.pmid: 17714991
references.citation: Cell. 2008 May 16;133(4):704-15
references.pmid: 18485877
references.citation: Br J Cancer. 2010 Apr 13;102(8):1265-75
references.pmid: 20332776
references.citation: Cell. 2006 Nov 3;127(3):469-80
references.pmid: 17081971
references.citation: PLoS Biol. 2009 Jun 2;7(6):e1000121
references.pmid: 19492080
references.citation: Digestion. 2002;66(3):131-44
references.pmid: 12481159
references.citation: Cancer Res. 2003 Sep 15;63(18):5821-8
references.pmid: 14522905
references.citation: Pathology. 2007 Jun;39(3):305-18
references.pmid: 17558857
references.citation: Stem Cells. 2006 Mar;24(3):506-13
references.pmid: 16239320
references.citation: Science. 1977 Aug 26;197(4306):893-5
references.pmid: 887927
references.citation: Nat Rev Cancer. 2002 Jun;2(6):442-54
references.pmid: 12189386
references.citation: Genes Dev. 2007 Jun 15;21(12):1478-83
references.pmid: 17575049
references.citation: Cancer Res. 2006 Oct 1;66(19):9339-44
references.pmid: 16990346
references.citation: PLoS One. 2012;7(6):e39069
references.pmid: 22745705
references.citation: PLoS One. 2011;6(8):e23899
references.pmid: 21909376
references.citation: Cancer Res. 2005 Jul 1;65(13):5506-11
references.pmid: 15994920
references.citation: Stem Cells. 2006 Jan;24(1):86-94
references.pmid: 16150918
references.citation: J Natl Cancer Inst. 2004 Oct 6;96(19):1420-5
references.pmid: 15467030
references.citation: Nature. 2007 Jan 4;445(7123):106-10
references.pmid: 17122772
references.citation: Cancer Res. 2007 Feb 1;67(3):1030-7
references.pmid: 17283135
references.citation: Cell Res. 2011 Apr;21(4):609-26
references.pmid: 21283129
references.citation: Int J Urol. 2007 Nov;14(11):1034-9
references.pmid: 17956532
references.citation: J Pathol. 2009 Jan;217(2):307-17
references.pmid: 19031475